Clinical trials
Terminated Phase 2/3 trials in Malaysia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2012 | 1 |
| 2015 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 2 |
| Pfizer | 2 |
| Bioven Sdn. Bhd. | 1 |
| Bristol-Myers Squibb | 1 |
| CSL Behring | 1 |
| EMD Serono | 1 |
| Hoffmann-La Roche | 1 |
| Intercept Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 2 |
| Biliary Atresia | 1 |
| COVID-19 | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Crohn Disease | 1 |
| Hidradenitis Suppurativa | 1 |
| Inflammatory Bowel Diseases | 1 |
| Lung Neoplasms | 1 |
| Lupus Nephritis | 1 |
| Nephritis | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.